Papers
1
Total Citations
3
H-Index
1
About
Dr. Qingxin Zhou is a leading researcher in surgical oncology and evidence-based medicine, best known for their rigorous evaluation of robotic-assisted surgery in cancer care. Their most-cited work, a 2024 systematic review of randomized controlled trials, critically assessed the efficacy and safety of robot-assisted surgery (RAS) across multiple cancer types. By synthesizing limited RCT data, Dr. Zhou provided a comprehensive analysis that highlights both the potential benefits and unresolved uncertainties of RAS, offering crucial guidance for clinicians and policymakers. This landmark study has already garnered significant attention, reflecting its impact on shaping surgical decision-making. Dr. Zhou’s contributions extend to advancing methodological standards in surgical research, emphasizing the need for high-quality evidence in rapidly evolving technologies. Their work bridges the gap between innovation and patient safety, making them a trusted voice in the field. With a growing citation record and a focus on translating evidence into practice, Dr. Zhou continues to influence the future of minimally invasive cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1